Meer dan een miljoen boeken binnen handbereik!
Bookbot

Eugen Gramer

    Glaukom
    Pharmakotherapie am Auge
    Pathogenesis and risk factors of glaucoma
    • During a closed international symposium held in Friedrichsruhe, Germany, the latest scientific results on the pathogenesis and risk factors of glaucoma were discussed, and this volume summarises the progress made in the detection and treatment of glaucomas. The 25 contributions cover such topics as compliance, medical therapy, wound healing, genetic risk factors, disk damage in relation to visual field loss, disk haemorrhages, intraocular pressure, low blood pressure, retinal ischemia, and the treatment of causal factors in glaucoma.

      Pathogenesis and risk factors of glaucoma
    • Pharmakotherapie am Auge

      Internationales Symposium der Universitätsaugenklinik Würzburg 10. November 1990

      This comprehensive work covers various aspects of glaucoma, including low-tension glaucoma, its prevalence, and associated background factors. It questions whether low-tension glaucoma qualifies as a true form of glaucoma, supported by histopathological studies that highlight its therapeutic implications. The text examines intraocular pressure treatment options and explores asymmetric visual field defects linked to unequal outflow facility through clinical studies. It also investigates differences in optic disc excavation forms between chronic simple glaucoma and low-tension glaucoma, utilizing laser tomographic scanning. The findings related to optic disc and hemorrhages offer therapeutic suggestions, while ocular microvascular responses to topical adrenergic therapy are discussed. Long-term effects of Timolol and adrenaline on the ciliary body are analyzed, along with the modulation of ciliary process vasculature by vasoactive substances. The text addresses apraclonidine hydrochloride therapy for glaucoma laser surgery and the management of intraocular pressure spikes induced by cycloplegics. It emphasizes the logic behind combination therapy for glaucoma, the role of beta-blockers in ocular blood flow, and the development of new combination medications requiring only two daily applications. Additionally, it covers clinical studies on nasal visual fields specific to glaucoma, dry eye diagnosis, treatment strategies for kerat

      Pharmakotherapie am Auge